Recent Finacing
Recent Raise
Invictus Oncology develops lower-toxicity platinum-based chemotherapies and a proprietary antibody-drug conjugate platform, advancing preclinical programs for lung, testicular, colorectal and pediatric cancers.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Invictus Oncology.
